Viral Clearance Market

Global Viral Clearance Market By Method (Viral Removal, Viral Inactivation), By Application (Recomninant Protein, Blood & Blood Products, Vaccines, Cell & Gene Therapy, Monoclonal Antibody, Stem Cell, Hormones, Others), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organisation, Academic Research Institues, Other), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Asia)

  • Report ID: HC-5
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 29
  • No. Of Pages: 290
  • Format:
  • Pub. Date: 2020-07-01
  • Share:
The global viral clearance market was valued at US$ 319.6 Million in 2019 and is projected to reach US$ X,XXX.1 Million by 2027, expanding at a CAGR of 20.6% during the forecast period. The market is driven by factors such as increasing government funding for the pharmaceutical and biotechnology industries, rise in number of new drug launches, R&D investments in life science, technology advancements in nanofiltration, and increase in emphasis on quality assurance and quality control departments.
 

Global Viral Clearance Market Outlook

Global Viral Clearance Market Outlook
On the basis of methods, the market is segmented into viral removal and viral inactivation. The viral removal is sub-segmented into chromatography, nanofiltration, and precipitation. The chromatography segment is expected to account for a significant share of the market between 2020 and 2027. Adoption of new technology and increasing need for filtration drive the demand for nanofiltration. The nanofiltration segment is expected to expand at a CAGR of XX.0% during the forecast period. The viral inactivation segment is further divided into low pH, solvent detergent method, pasteurization, and others. The low pH segment is estimated to expand at a X0.6% CAGR in the forecast period, between 2020 and 2027.

The viral removal segment accounted for the dominant share of the market in 2019. This segment is also expected to expand at a XX.7% CAGR, in the the forecast period, between 2020 and 2027. The significant share of this segment is primarily attributed to the growth of R&D activities by biopharmaceutical companies; high acceptance of this method; and the accuracy, speed, and flexibility provided by the method in life sciences research.

Based on applications, the global viral clearance market is segregated into recombinant protein, blood and blood products, vaccines, cell and gene therapy, monoclonal antibody, stem cell, hormones, and others. The recombinant proteins segment is expected to dominate the market during the forecast period due to large-scale production of recombinant protein, it finds it’s application in  applications in the field of proteomics, structural biology, and protein therapeutics. When large quantities of protein needs to be produced, cells must be cultured in large volumes by the implementation of fermentation techniques, as the production of these proteins increases the demand for the viral clearance process. The stem cell segment is estimated to expand at a CAGR of 21.2% during the forecast period, due to the increasing use of stem cell in the treatment of various diseases, rising public and private funding for stem cell research, and growing awareness about stem cell therapies. 

On the basis of end-users, the viral clearance market is Classified as medical device companies, laboratories, animal facilities, cell banks, and consultants, and media/sera manufacturers, pharmaceutical & biotechnology companies, contract research organizations (CROs), academic research institutes, and others. The contract research organizations  (CROs) segment is expected to register a CAGR of 20.9% between 2020 and 2027. Rapid growth in this segment is attributed to the ability of CROs to invest in infrastructure for drug discovery and rising trend of outsourcing drug discovery services to CROs by pharmaceutical companies, academic institutes, and biotechnology companies.
 

Global Viral Clearance Market Segment

Global Viral Clearance Market Segment
In terms of regions, the market has been fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is anticipated to expand at a CAGR of 21.1% during the forecast period,. Rise in funding for medical research, large presence of a large number of CROs to provide preclinical and clinical research services in China, increase in aging population, growth in pharmaceutical R&D expenditures in emerging countries such as India, China, and surge in pharmaceutical manufacturing boost the growth of the viral clearance market in Asia Pacific.

North America is expected to account for a significant share of the market. The market in the region is driven by the growth in the pharmaceuticals industry and rising number of drug approvals. Increasing prevalence of diseases, growing production of monoclonal antibodies, and rising government support for the development of drugs are some factors driving the viral clearance market.
 

Global Viral Clearance Market Regional Outlook

Global Viral Clearance Market Regional Outlook

Key players in the market include Wuxi Biologics, Merck KGaA,  and  Charles River Laboratories International Inc. They considered as key players in the market based on their different varieties of product availability, regional presence, better supply chain management system, and increasing demand for products.

Global Viral Clearance Market Major Player Anlaysis

Global Viral Clearance Market Competitive Analysis

Global Viral Clearance Market Report Attribute
 
Report Attribute Report Details
Base Year 2019
Historical Data 2017
Forecast Year 2027
Growth Rate 20.6%
Market Value in 2019 US$ 319.6 Million
Regional scope Global - North America, Europe, China, Rest of Asia Pacific, Central & South America, and the Middle East & Africa 
Segments covered By Method (Viral Removal, Viral Inactivation), By Application (Recomninant Protein, Blood & Blood Products, Vaccines, Cell & Gene Therapy, Monoclonal Antibody, Stem Cell, Hormones, Others), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organisation, Academic Research Institues, Other)
Key companies profiled WuXi Biologics,CHARLES RIVER LABORATORIES INTERNATIONAL, INC,Merck KGaA,Texcell SA,Kedrion S.p.A,Lonza,VIRUSURE,Vironova,Eurofins Scientific,Cleancells
 
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Viral Clearance Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Viral Clearance Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Viral Clearance Market - Supply Chain
  4.5. Global Viral Clearance Market Forecast
     4.5.1. Viral Clearance Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Viral Clearance Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Viral Clearance Market Absolute $ Opportunity
5. Global Viral Clearance Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Viral Clearance Market Size and Volume Forecast by Types
     5.3.1. Viral Removal
     5.3.2. Viral Inactivation
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Viral Clearance Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Viral Clearance Market Size and Volume Forecast by Applications
     6.3.1. Recomninant Protein
     6.3.2. Blood & Blood Products
     6.3.3. Vaccines
     6.3.4. Cell & Gene Therapy
     6.3.5. Monoclonal Antibody
     6.3.6. Stem Cell
     6.3.7. Hormones
     6.3.8. Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Viral Clearance Market Analysis and Forecast by End Users
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by End Users
     7.2.2. Y-o-Y Growth Projections by End Users
  7.3. Viral Clearance Market Size and Volume Forecast by End Users
     7.3.1. Pharmaceutical & Biotechnology Companies
     7.3.2. Contract Research Organisation
     7.3.3. Academic Research Institues
     7.3.4. Other
  7.4. Absolute $ Opportunity Assessment by End Users
  7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Viral Clearance Market Analysis and Forecast by Region
  8.1. Market Trends
  8.2. Introduction
     8.2.1. Basis Point Share (BPS) Analysis by Region
     8.2.2. Y-o-Y Growth Projections by Region
  8.3. Viral Clearance Market Size and Volume Forecast by Region
     8.3.1. North America
     8.3.2. Latin America
     8.3.3. Europe
     8.3.4. Asia Pacific
     8.3.5. Middle East and Africa (MEA)
  8.4. Absolute $ Opportunity Assessment by Region
  8.5. Market Attractiveness/Growth Potential Analysis by Region
  8.6. Global Viral Clearance Demand Share Forecast, 2019-2026
9. North America Viral Clearance Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
  9.2. North America Viral Clearance Market Size and Volume Forecast by Country
     9.2.1. U.S.
     9.2.2. Canada
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. North America Viral Clearance Market Size and Volume Forecast by Types
     9.4.1. Viral Removal
     9.4.2. Viral Inactivation
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. North America Viral Clearance Market Size and Volume Forecast by Applications
     9.7.1. Recomninant Protein
     9.7.2. Blood & Blood Products
     9.7.3. Vaccines
     9.7.4. Cell & Gene Therapy
     9.7.5. Monoclonal Antibody
     9.7.6. Stem Cell
     9.7.7. Hormones
     9.7.8. Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. North America Viral Clearance Market Size and Volume Forecast by End Users
     9.10.1. Pharmaceutical & Biotechnology Companies
     9.10.2. Contract Research Organisation
     9.10.3. Academic Research Institues
     9.10.4. Other
  9.11. Basis Point Share (BPS) Analysis by End Users
  9.12. Y-o-Y Growth Projections by End Users
  9.13. Market Attractiveness/Growth Potential Analysis
     9.13.1. By Country
     9.13.2. By Product Type
     9.13.3. By Application
  9.14. North America Viral Clearance Demand Share Forecast, 2019-2026
10. Latin America Viral Clearance Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Latin America Average Pricing Analysis
  10.2. Latin America Viral Clearance Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
  10.4. Latin America Viral Clearance Market Size and Volume Forecast by Types
     10.4.1. Viral Removal
     10.4.2. Viral Inactivation
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Latin America Viral Clearance Market Size and Volume Forecast by Applications
     10.7.1. Recomninant Protein
     10.7.2. Blood & Blood Products
     10.7.3. Vaccines
     10.7.4. Cell & Gene Therapy
     10.7.5. Monoclonal Antibody
     10.7.6. Stem Cell
     10.7.7. Hormones
     10.7.8. Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Latin America Viral Clearance Market Size and Volume Forecast by End Users
     10.10.1. Pharmaceutical & Biotechnology Companies
     10.10.2. Contract Research Organisation
     10.10.3. Academic Research Institues
     10.10.4. Other
  10.11. Basis Point Share (BPS) Analysis by End Users
  10.12. Y-o-Y Growth Projections by End Users
  10.13. Market Attractiveness/Growth Potential Analysis
     10.13.1. By Country
     10.13.2. By Product Type
     10.13.3. By Application
  10.14. Latin America Viral Clearance Demand Share Forecast, 2019-2026
11. Europe Viral Clearance Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Europe Average Pricing Analysis
  11.2. Europe Viral Clearance Market Size and Volume Forecast by Country
     11.2.1. Germany
     11.2.2. France
     11.2.3. Italy
     11.2.4. U.K.
     11.2.5. Spain
     11.2.6. Russia
     11.2.7. Rest of Europe
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Europe Viral Clearance Market Size and Volume Forecast by Types
     11.4.1. Viral Removal
     11.4.2. Viral Inactivation
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Europe Viral Clearance Market Size and Volume Forecast by Applications
     11.7.1. Recomninant Protein
     11.7.2. Blood & Blood Products
     11.7.3. Vaccines
     11.7.4. Cell & Gene Therapy
     11.7.5. Monoclonal Antibody
     11.7.6. Stem Cell
     11.7.7. Hormones
     11.7.8. Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Europe Viral Clearance Market Size and Volume Forecast by End Users
     11.10.1. Pharmaceutical & Biotechnology Companies
     11.10.2. Contract Research Organisation
     11.10.3. Academic Research Institues
     11.10.4. Other
  11.11. Basis Point Share (BPS) Analysis by End Users
  11.12. Y-o-Y Growth Projections by End Users
  11.13. Market Attractiveness/Growth Potential Analysis
     11.13.1. By Country
     11.13.2. By Product Type
     11.13.3. By Application
  11.14. Europe Viral Clearance Demand Share Forecast, 2019-2026
12. Asia Pacific Viral Clearance Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Asia Pacific Average Pricing Analysis
  12.2. Asia Pacific Viral Clearance Market Size and Volume Forecast by Country
     12.2.1. China
     12.2.2. Japan
     12.2.3. South Korea
     12.2.4. India
     12.2.5. Australia
     12.2.6. Rest of Asia Pacific (APAC)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Asia Pacific Viral Clearance Market Size and Volume Forecast by Types
     12.4.1. Viral Removal
     12.4.2. Viral Inactivation
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Asia Pacific Viral Clearance Market Size and Volume Forecast by Applications
     12.7.1. Recomninant Protein
     12.7.2. Blood & Blood Products
     12.7.3. Vaccines
     12.7.4. Cell & Gene Therapy
     12.7.5. Monoclonal Antibody
     12.7.6. Stem Cell
     12.7.7. Hormones
     12.7.8. Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Asia Pacific Viral Clearance Market Size and Volume Forecast by End Users
     12.10.1. Pharmaceutical & Biotechnology Companies
     12.10.2. Contract Research Organisation
     12.10.3. Academic Research Institues
     12.10.4. Other
  12.11. Basis Point Share (BPS) Analysis by End Users
  12.12. Y-o-Y Growth Projections by End Users
  12.13. Market Attractiveness/Growth Potential Analysis
     12.13.1. By Country
     12.13.2. By Product Type
     12.13.3. By Application
  12.14. Asia Pacific Viral Clearance Demand Share Forecast, 2019-2026
13. Middle East & Africa Viral Clearance Market Analysis and Forecast
  13.1. Introduction
     13.1.1. Basis Point Share (BPS) Analysis by Country
     13.1.2. Y-o-Y Growth Projections by Country
     13.1.3. Middle East & Africa Average Pricing Analysis
  13.2. Middle East & Africa Viral Clearance Market Size and Volume Forecast by Country
     13.2.1. Saudi Arabia
     13.2.2. South Africa
     13.2.3. UAE
     13.2.4. Rest of Middle East & Africa (MEA)
  13.3. Absolute $ Opportunity Assessment by Country
  13.4. Middle East & Africa Viral Clearance Market Size and Volume Forecast by Types
     13.4.1. Viral Removal
     13.4.2. Viral Inactivation
  13.5. Basis Point Share (BPS) Analysis by Types
  13.6. Y-o-Y Growth Projections by Types
  13.7. Middle East & Africa Viral Clearance Market Size and Volume Forecast by Applications
     13.7.1. Recomninant Protein
     13.7.2. Blood & Blood Products
     13.7.3. Vaccines
     13.7.4. Cell & Gene Therapy
     13.7.5. Monoclonal Antibody
     13.7.6. Stem Cell
     13.7.7. Hormones
     13.7.8. Others
  13.8. Basis Point Share (BPS) Analysis by Applications
  13.9. Y-o-Y Growth Projections by Applications
  13.10. Middle East & Africa Viral Clearance Market Size and Volume Forecast by End Users
     13.10.1. Pharmaceutical & Biotechnology Companies
     13.10.2. Contract Research Organisation
     13.10.3. Academic Research Institues
     13.10.4. Other
  13.11. Basis Point Share (BPS) Analysis by End Users
  13.12. Y-o-Y Growth Projections by End Users
  13.13. Market Attractiveness/Growth Potential Analysis
     13.13.1. By Country
     13.13.2. By Product Type
     13.13.3. By Application
  13.14. Middle East & Africa Viral Clearance Demand Share Forecast, 2019-2026
14. Competition Landscape
  14.1. Global Viral Clearance Market: Market Share Analysis
  14.2. Viral Clearance Distributors and Customers
  14.3. Viral Clearance Market: Competitive Dashboard
  14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     14.4.1. WuXi Biologics
     14.4.2. CHARLES RIVER LABORATORIES INTERNATIONAL, INC
     14.4.3. Merck KGaA
     14.4.4. Texcell SA
     14.4.5. Kedrion S.p.A 
     14.4.6. Lonza
     14.4.7. VIRUSURE
     14.4.8. Vironova 
     14.4.9. Eurofins Scientific
     14.4.10. Cleancells

Global Viral Clearance Market Segment:

By Method:
  • Viral Removal
    • Chromatography
    • Nanofiltration
    • Precipitation
  • Viral Inactivation
    • Low Ph
    • Solvent Detergent Method
    • Pasteurization
    • Others
By Application:
  • Recomninant Protein
  • Blood & Blood Products
  • Vaccines
  • Cell & Gene Therapy
  • Monoclonal Antibody
  • Stem Cell
  • Hormones
  • Others 
By End User :
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organisation
  • Academic Research Institues
  • Other
By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Asia

Buy Report